Plasma Transthyretin as a Predictor of Amnestic Mild Cognitive Impairment Conversion to Dementia
Plasma Transthyretin as a Predictor of Amnestic Mild Cognitive Impairment Conversion to Dementia is a paper indexed in ScholarIQ from OpenAlex.
How many citations does Plasma Transthyretin as a Predictor of Amnestic Mild Cognitive Impairment Conversion to Dementia have?
Plasma Transthyretin as a Predictor of Amnestic Mild Cognitive Impairment Conversion to Dementia has 26 citations in the OpenAlex counts ScholarIQ stores.
When was Plasma Transthyretin as a Predictor of Amnestic Mild Cognitive Impairment Conversion to Dementia published?
Plasma Transthyretin as a Predictor of Amnestic Mild Cognitive Impairment Conversion to Dementia has 2019 year in the ScholarIQ index.
What is the open-access status of Plasma Transthyretin as a Predictor of Amnestic Mild Cognitive Impairment Conversion to Dementia?
Plasma Transthyretin as a Predictor of Amnestic Mild Cognitive Impairment Conversion to Dementia has gold oa status in the ScholarIQ index.
What is the DOI of Plasma Transthyretin as a Predictor of Amnestic Mild Cognitive Impairment Conversion to Dementia?
The DOI for Plasma Transthyretin as a Predictor of Amnestic Mild Cognitive Impairment Conversion to Dementia is on the source record.
What is the PMID of Plasma Transthyretin as a Predictor of Amnestic Mild Cognitive Impairment Conversion to Dementia?
The PMID for Plasma Transthyretin as a Predictor of Amnestic Mild Cognitive Impairment Conversion to Dementia is on the source record.
What is the OpenAlex record for Plasma Transthyretin as a Predictor of Amnestic Mild Cognitive Impairment Conversion to Dementia?
The OpenAlex for Plasma Transthyretin as a Predictor of Amnestic Mild Cognitive Impairment Conversion to Dementia is on the source record.